Di 88-year-old don dey suffer from respiratory infection for ova one week and dem admit am to Rome Gemelli hospital on Friday ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

By analyzing multiple emphysema and COPD patient datasets, SPP1 is significantly upregulated in the lungs of patients, ...

Pulmonx Corporation’s LUNG share price has surged by 32.23%, which has investors questioning if this is right time to sell.

Cystic Fibrosis Damages the Immune System Early on Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease ...

This study is led by Dr. Lianyong Han and Dr. Tobias Stoeger in Germany (Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, German Research ...

According to the American Lung Association ... with 3.5 million also diagnosed with emphysema, which is life-threatening with no cure. The new treatment, the Zephyr Valve, aims to help ease ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

The Vatican released a statement on Tuesday evening saying laboratory tests, chest X-rays, and the clinical condition of the ...